As of 2025, retatrutide has not received marketing authorisation from the MHRA or EMA and is not available as a licensed treatment in the UK through the NHS or via private prescribing
"It's really interesting that the same medication, slightly different dosing, might be covered if a patient has Type 2 diabetes, but if they only have obesity, it's nixed completely
When several drugs from the same manufacturer enter shortage simultaneously, the underlying issue is plant-level and may affect more products
KLOW Peptide Blend: A Comprehensive Approach to Healing, Inflammation Control, and Tissue Regeneration Peptide therapy has rapidly emerged as one of the most promising frontiers in regenerative and functional medicine
If symptoms persist or your cat seems unwell, stop the product and contact your veterinarian